Product Information
EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 100-150 MG TAB is a generic product labeled by Aurobindo Pharma Limited, priced at $10.1945 per EA under NDC 59651016530. Its NADAC has been published 54 times since Sep 24, 2025.
FDA first approved this application on Mar 9, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Emtricitabine and Tenofovir Disoproxil Fumarate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 100-150 MG TAB
Emtricitabine and Tenofovir Disoproxil FumarateStrength
100; 150 mg/1; mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
59651016530
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
4/22/2026
Active Ingredients
EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATEApproval Type
Generic (ANDA)
FDA Application
ANDA211640FDA Approved
3/9/2023
TE Code
AB
On Market Since
3/9/2023
Pharmacological Classes
Price Statistics
The NADAC for EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 100-150 MG TAB has been published 54 times since Sep 24, 2025, and over the history we have for it it has declined 3.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $10.1945 per EA |
|---|---|
| All-time high | $11.2736 (Jan 14, 2026) |
| All-time low | $10.1523 (Feb 18, 2026) |
| 52-week high | $11.2736 |
| 52-week low | $10.1523 |
| Median price | $10.1945 |
| Average price | $10.4290 |
| Largest weekly change | -6.7% (Jan 21, 2026) |
| Weeks tracked | 54 |
| Tracking since | Sep 24, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurobindo Pharma Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Emtricitabine and Tenofovir Disoproxil Fumarate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 100-150 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 100-150 MG TAB, manufactured by Aurobindo Pharma Limited, is $10.1945 per EA (NDC 59651016530), effective Sep 30, 2026.
How has the price of EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 100-150 MG TAB changed over time?
Over the history we have for it, the NADAC for EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 100-150 MG TAB has declined 3.8%. It has been tracked across 54 weekly CMS publications since Sep 24, 2025.
What are the highest and lowest recorded NADAC prices for EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 100-150 MG TAB?
Since Sep 24, 2025, the NADAC for EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 100-150 MG TAB has ranged from a low of $10.1523 (Feb 18, 2026) to a high of $11.2736 (Jan 14, 2026), with a median of $10.1945 per EA.
Are there cheaper alternatives to EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 100-150 MG TAB?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 100-150 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 100-150 MG TAB?
EMTRICITABINE-TENOFOVIR DISOPROXIL FUMARATE 100-150 MG TAB (NDC 59651016530) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.